Historical Stock Price
ARGS historical stock prices picture
ARGS (ARGS) has the following price history information. Looking back at ARGS historical stock prices for the last five trading days, on November 28, 2018, ARGS opened at $0.11, traded as high as $0.13 and as low as $0.11, and closed at $0.12. Trading volume was a total of 21.80K shares. On November 29, 2018, ARGS opened at $0.12, traded as high as $0.14 and as low as $0.12, and closed at $0.12. Trading volume was a total of 9.60K shares. On November 30, 2018, ARGS opened at $0.11, traded as high as $0.12 and as low as $0.07, and closed at $0.09. Trading volume was a total of 296.70K shares. On December 03, 2018, ARGS opened at $0.08, traded as high as $0.11 and as low as $0.08, and closed at $0.10. Trading volume was a total of 200.00K shares. On December 04, 2018, ARGS opened at $0.10, traded as high as $0.11 and as low as $0.10, and closed at $0.10. Trading volume was a total of 67.40K shares.

ARGS Historical Stock Prices By Date:

ARGS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARGS shares, starting with a $10,000 purchase of ARGS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 12/04/2018
Start price/share: $200.00
End price/share: $0.10
Dividends collected/share: $0.00
Total return: -99.95%
Average Annual Total Return: -80.28%
Starting investment: $10,000.00
Ending investment: $5.00
Years: 4.68
Date Open High Low Close Volume
11/28/2018 $0.11 $0.13 $0.11 $0.12 21.80K
11/29/2018 $0.12 $0.14 $0.12 $0.12 9.60K
11/30/2018 $0.11 $0.12 $0.07 $0.09 296.70K
12/03/2018 $0.08 $0.11 $0.08 $0.10 200.00K
12/04/2018 $0.10 $0.11 $0.10 $0.10 67.40K
Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer based on Co.'s proprietary precision immunotherapy technology platform called Arcelis. Co.'s proprietary Arcelis precision immunotherapy technology platform utilizes biological components from a patient's own cancer cells or virus to generate individualized immunotherapies. Co.'s primary product candidate is rocapuldencel-T, which is for the treatment of metastatic renal cell carcinoma and other cancers. Co. is also developing AGS-004, for the treatment of Human Immunodeficiency Virus.
Date Close
11/28/2018$0.12
11/29/2018$0.12
11/30/2018$0.09
12/03/2018$0.10
12/04/2018$0.10
ARGS is categorized under the Healthcare sector; below are some other companies in the same sector:

ARIA Historical Stock Prices
ARNA Historical Stock Prices
ARQL Historical Stock Prices
ARRY Historical Stock Prices
ARTC Historical Stock Prices
ARWR Historical Stock Prices
ASEI Historical Stock Prices
ASMB Historical Stock Prices
ASNS Historical Stock Prices
ASPX Historical Stock Prices

Email EnvelopeFree ARGS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ARGS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.